James Yu

A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer

Dae Won Kim, Elaine Tan, Junmin Zhou et al. · British Journal of Cancer · 2021 · 47 citations · Full text

Medicine, Oncology, Pharmacology +10

Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections

James Yu, Juan D. Diaz, Steven C. Goldstein et al. · Transplantation and Cellular Therapy · 2021 · 40 citations · Full text

Veterinary Medicine, Hematology, Microbiology +15

A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer

Richard D. Kim, Elaine Tan, Emily Wang et al. · The Oncologist · 2020 · 33 citations · Full text

Medicine, Oncology, Pharmacology +15

A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors

Mengni Guo, Jieying Liu, Ruoyu Miao et al. · Journal of Immunotherapy · 2022 · 16 citations · Full text

Life Sciences, Immunology, Oncology +16

Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective Cohort Study

James Yu, Yuan Du, Sarfraz Ahmad et al. · Transplantation and Cellular Therapy · 2021 · 14 citations · Full text

Medicine, Hematology, Oncology +16